BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17122074)

  • 1. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis.
    Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW
    Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.
    Gutman G; Barak V; Maslovitz S; Amit A; Lessing JB; Geva E
    Fertil Steril; 2008 Apr; 89(4):922-6. PubMed ID: 18343373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LAPS-FSH: a new and effective long-acting follicle-stimulating hormone analogue for the treatment of infertility.
    Jung S; Park Y; Kim Y; Kim YY; Choi HJ; Son WC; Kwon S
    Reprod Fertil Dev; 2014 Oct; 26(8):1142-53. PubMed ID: 24044514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of follicular development by direct single injection of vascular endothelial growth factor gene fragments into the ovary of miniature gilts.
    Shimizu T; Jiang JY; Iijima K; Miyabayashi K; Ogawa Y; Sasada H; Sato E
    Biol Reprod; 2003 Oct; 69(4):1388-93. PubMed ID: 12826586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.
    Zhang YL; Guo KP; Ji SY; Liu XM; Wang P; Wu J; Gao L; Jiang TQ; Xu T; Fan HY
    Hum Reprod; 2016 Jan; 31(1):169-82. PubMed ID: 26621853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides.
    LaPolt PS; Nishimori K; Fares FA; Perlas E; Boime I; Hsueh AJ
    Endocrinology; 1992 Dec; 131(6):2514-20. PubMed ID: 1446593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.
    Fauser BC; Mannaerts BM; Devroey P; Leader A; Boime I; Baird DT
    Hum Reprod Update; 2009; 15(3):309-21. PubMed ID: 19182099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of direct ovarian injection of vascular endothelial growth factor gene fragments on follicular development in immature female rats.
    Shimizu T; Iijima K; Miyabayashi K; Ogawa Y; Miyazaki H; Sasada H; Sato E
    Reproduction; 2007 Nov; 134(5):677-82. PubMed ID: 17965258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGFβ1) in the regulation of ovarian angiogenesis.
    Kuo SW; Ke FC; Chang GD; Lee MT; Hwang JJ
    J Cell Physiol; 2011 Jun; 226(6):1608-19. PubMed ID: 20945379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
    Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
    Bouloux PM; Handelsman DJ; Jockenhövel F; Nieschlag E; Rabinovici J; Frasa WL; de Bie JJ; Voortman G; Itskovitz-Eldor J;
    Hum Reprod; 2001 Aug; 16(8):1592-7. PubMed ID: 11473948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FSH-HIF-1α-VEGF Pathway Is Critical for Ovulation and Oocyte Health but Not Necessary for Follicular Growth in Mice.
    Li C; Liu Z; Li W; Zhang L; Zhou J; Sun M; Zhou J; Yao W; Zhang X; Wang H; Tao J; Shen M; Liu H
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32141513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adiposity enhances intrafollicular estradiol levels in normoandrogenic ovulatory women receiving gonadotropin-releasing hormone analog/recombinant human follicle-stimulating hormone therapy for in vitro fertilization.
    Dumesic DA; Lesnick TG; Abbott DH
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1438-41. PubMed ID: 17244784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women.
    Filicori M; Cognigni GE; Tabarelli C; Pocognoli P; Taraborrelli S; Spettoli D; Ciampaglia W
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1156-61. PubMed ID: 11889180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and angiopoietin production by primate follicles during culture is a function of growth rate, gonadotrophin exposure and oxygen milieu.
    Fisher TE; Molskness TA; Villeda A; Zelinski MB; Stouffer RL; Xu J
    Hum Reprod; 2013 Dec; 28(12):3263-70. PubMed ID: 24045779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.
    Eldar-Geva T; Robertson DM; Cahir N; Groome N; Gabbe MP; Maclachlan V; Healy DL
    J Clin Endocrinol Metab; 2000 Feb; 85(2):607-13. PubMed ID: 10690863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The molecular design and drug development of recombinant long-acting follicle stimulating hormone].
    Diao Y; Lin JS
    Yao Xue Xue Bao; 2012 Apr; 47(4):421-6. PubMed ID: 22799021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine and paracrine control of follicular development and ovulation rate in farm species.
    Hunter MG; Robinson RS; Mann GE; Webb R
    Anim Reprod Sci; 2004 Jul; 82-83():461-77. PubMed ID: 15271473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.